Aldesleukin Completed Phase 3 Trials for Renal Cancers Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00003126Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer
NCT00018941Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
NCT00053820Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer
NCT00053807Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer
NCT00416871Interleukin-2 and Interferon in Treating Patients With Metastatic Kidney Cancer
NCT00416429Medroxyprogesterone or Interferon and/or Aldesleukin in Treating Patients With Metastatic Kidney Cancer